<DOC>
	<DOCNO>NCT01991184</DOCNO>
	<brief_summary>This open-label , Phase I study evaluate safety , tolerability , pharmacokinetics increase dos GDC-0853 patient relapse refractory B-cell non-Hodgkin 's lymphoma chronic lymphocytic leukemia . In dose-expansion part , GDC-0853 assess subset patient .</brief_summary>
	<brief_title>A Study GDC-0853 Patients With Resistant B-Cell Lymphoma Chronic Lymphocytic Leukemia .</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<criteria>Age &gt; /= 18 year ECOG score 01 One following histologicallydocumented hematologic malignancy effective standard therapy exists : indolent non Hodgkin 's lymphoma ( NHL ) , follicular lymphoma ( FL ) , diffuse large Bcell lymphoma ( DLBCL ) , mantle cell lymphoma ( MCL ) , chronic lymphocytic leukemia ( CLL ) At least one site disease , see CT scan , &gt; 1.5 cm great transverse diameter &gt; 1.0 cm short axis diameter ( except patient CLL ) An available tumor specimen Adequate hematologic organ function For female patient childbearing potential male patient partner childbearing potential , use effective contraceptive ( ) define protocol duration study Life expectancy &lt; 12 week &lt; 3 week since last antitumor therapy , include chemotherapy , biologic , experimental , hormonal radiotherapy ( exception leuprolide similar medication prostate cancer ) Recent major surgical procedure traumatic injury , unhealed incision wound Active infection require IV antibiotic Clinically significant history liver disease , include viral hepatitis , current alcohol abuse , cirrhosis . Primary CNS malignancy untreated/active CNS metastasis ( progress require anticonvulsant corticosteroid symptomatic control ) History malignancy within 5 year prior screen , except appropriately treat carcinoma situ cervix , nonmelanoma skin cancer , Stage I uterine cancer , cancer similar outcome Cardiovascular dysfunction , include ventricular dysrhythmias risk factor ventricular dysrhythmias Pregnancy , lactation Any diseases contraindicates use investigational drug may affect interpretation result render patient high risk treatment complication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>